Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study

• Heli Harvala,
• Robin Gopal,
• Monika Patel,
• Maria Zambon,
• David Roberts,
• Abigail Lamikanra,
• Rutger Ploeg,
• Marieke Hoogerwerf,
• Hans Zaaijer,
• Boris Hogema,
• Chantal Reusken,
• Ellen van der Schoot,
• Johan Reimerink

Affiliations

Heli Harvala

National Microbiology Services NHS Blood and Transplant London UK

Robin Gopal

Virology Reference Department National Infection Service, Public Health England London UK

Monika Patel

Virology Reference Department National Infection Service, Public Health England London UK

Maria Zambon

Virology Reference Department National Infection Service, Public Health England London UK

David Roberts

NHS Blood and Transplant John Radcliffe Hospital Oxford UK

Abigail Lamikanra

NHS Blood and Transplant John Radcliffe Hospital Oxford UK

Rutger Ploeg

Nuffield Department of Surgical Sciences University of Oxford Oxford UK

Marieke Hoogerwerf

Centre for Infectious Disease Control, WHO COVID‐19 Reference Laboratory National Institute for Public Health and the Environment Bilthoven The Netherlands

Hans Zaaijer

Deparment of Immunopathology Sanquin Research and Landsteiner Laboratory Academic Medical Centre Amsterdam The Netherlands

Boris Hogema

Deparment of Immunopathology Sanquin Research and Landsteiner Laboratory Academic Medical Centre Amsterdam The Netherlands

Chantal Reusken

Centre for Infectious Disease Control, WHO COVID‐19 Reference Laboratory National Institute for Public Health and the Environment Bilthoven The Netherlands

Ellen van der Schoot

Deparment of Immunopathology Sanquin Research and Landsteiner Laboratory Academic Medical Centre Amsterdam The Netherlands

Johan Reimerink

Centre for Infectious Disease Control, WHO COVID‐19 Reference Laboratory National Institute for Public Health and the Environment Bilthoven The Netherlands